Enzon Pharmaceuticals, Inc.

BST:EZ1 Stock Report

Market Cap: €5.1m

Enzon Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Enzon Pharmaceuticals has a total shareholder equity of $46.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $47.3M and $438.0K respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$46.63m
EquityUS$46.84m
Total liabilitiesUS$438.00k
Total assetsUS$47.28m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: EZ1's short term assets ($47.0M) exceed its short term liabilities ($438.0K).

Long Term Liabilities: EZ1 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: EZ1 is debt free.

Reducing Debt: EZ1 has not had any debt for past 5 years.

Debt Coverage: EZ1 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: EZ1 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies